human triple negative breast cancer cell lines hcc1937 Search Results


97
ATCC hcc1937
Hcc1937, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+triple+negative+breast+cancer+cell+lines+hcc1937/pm37220155-103-15-20?v=ATCC
Average 97 stars, based on 1 article reviews
hcc1937 - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

95
ATCC human breast cancer cell lines
Human Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+triple+negative+breast+cancer+cell+lines+hcc1937/pm31894262-21-0-32?v=ATCC
Average 95 stars, based on 1 article reviews
human breast cancer cell lines - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

93
DSMZ hcc1937
Figure 7. EZH2 Inhibition Impairs Metastasis in TNBC Subtype-Specific PDX Models (A) EZH2 and GATA3 expression of the METABRIC dataset of 347 breast cancer patients, available in cBioportal and grouped by Pietenpol TNBC subtypes. Data represent median ± interquartile range (Wilcox t test). (B) Quantitative analysis of the invasive potential of <t>HCC1937</t> (BL-1), MDA-MB-468 (BL-1), BT-549 (M), CAL-120 (M), MDA-MB-453 (LAR), SUM185 (LAR), and CAL-148 (LAR) cell lines following treatment with vehicle or drug (5 mM GSK-126 for 5 days) and quantification of invasive cells of six distinct images in each replicate (n = 3) per group. The invasion of vehicle-treated cells was set at 1.
Hcc1937, supplied by DSMZ, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+triple+negative+breast+cancer+cell+lines+hcc1937/pm31968251-247-10-29?v=DSMZ
Average 93 stars, based on 1 article reviews
hcc1937 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

96
ATCC sample collection human breast cancer cell lines
Figure 7. EZH2 Inhibition Impairs Metastasis in TNBC Subtype-Specific PDX Models (A) EZH2 and GATA3 expression of the METABRIC dataset of 347 breast cancer patients, available in cBioportal and grouped by Pietenpol TNBC subtypes. Data represent median ± interquartile range (Wilcox t test). (B) Quantitative analysis of the invasive potential of <t>HCC1937</t> (BL-1), MDA-MB-468 (BL-1), BT-549 (M), CAL-120 (M), MDA-MB-453 (LAR), SUM185 (LAR), and CAL-148 (LAR) cell lines following treatment with vehicle or drug (5 mM GSK-126 for 5 days) and quantification of invasive cells of six distinct images in each replicate (n = 3) per group. The invasion of vehicle-treated cells was set at 1.
Sample Collection Human Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+triple+negative+breast+cancer+cell+lines+hcc1937/us12492429-2729-0-30?v=ATCC
Average 96 stars, based on 1 article reviews
sample collection human breast cancer cell lines - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

94
ATCC human gdna hcc1937
Figure 7. EZH2 Inhibition Impairs Metastasis in TNBC Subtype-Specific PDX Models (A) EZH2 and GATA3 expression of the METABRIC dataset of 347 breast cancer patients, available in cBioportal and grouped by Pietenpol TNBC subtypes. Data represent median ± interquartile range (Wilcox t test). (B) Quantitative analysis of the invasive potential of <t>HCC1937</t> (BL-1), MDA-MB-468 (BL-1), BT-549 (M), CAL-120 (M), MDA-MB-453 (LAR), SUM185 (LAR), and CAL-148 (LAR) cell lines following treatment with vehicle or drug (5 mM GSK-126 for 5 days) and quantification of invasive cells of six distinct images in each replicate (n = 3) per group. The invasion of vehicle-treated cells was set at 1.
Human Gdna Hcc1937, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+triple+negative+breast+cancer+cell+lines+hcc1937/pmc12570316-36-0-4?v=ATCC
Average 94 stars, based on 1 article reviews
human gdna hcc1937 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

97
ATCC human tnbc
Figure 7. EZH2 Inhibition Impairs Metastasis in TNBC Subtype-Specific PDX Models (A) EZH2 and GATA3 expression of the METABRIC dataset of 347 breast cancer patients, available in cBioportal and grouped by Pietenpol TNBC subtypes. Data represent median ± interquartile range (Wilcox t test). (B) Quantitative analysis of the invasive potential of <t>HCC1937</t> (BL-1), MDA-MB-468 (BL-1), BT-549 (M), CAL-120 (M), MDA-MB-453 (LAR), SUM185 (LAR), and CAL-148 (LAR) cell lines following treatment with vehicle or drug (5 mM GSK-126 for 5 days) and quantification of invasive cells of six distinct images in each replicate (n = 3) per group. The invasion of vehicle-treated cells was set at 1.
Human Tnbc, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+triple+negative+breast+cancer+cell+lines+hcc1937/pmc07856896__ADVS___8___2003049___s001-16-4-26?v=ATCC
Average 97 stars, based on 1 article reviews
human tnbc - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

99
ATCC breast cancer cell lines
Figure 7. EZH2 Inhibition Impairs Metastasis in TNBC Subtype-Specific PDX Models (A) EZH2 and GATA3 expression of the METABRIC dataset of 347 breast cancer patients, available in cBioportal and grouped by Pietenpol TNBC subtypes. Data represent median ± interquartile range (Wilcox t test). (B) Quantitative analysis of the invasive potential of <t>HCC1937</t> (BL-1), MDA-MB-468 (BL-1), BT-549 (M), CAL-120 (M), MDA-MB-453 (LAR), SUM185 (LAR), and CAL-148 (LAR) cell lines following treatment with vehicle or drug (5 mM GSK-126 for 5 days) and quantification of invasive cells of six distinct images in each replicate (n = 3) per group. The invasion of vehicle-treated cells was set at 1.
Breast Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+triple+negative+breast+cancer+cell+lines+hcc1937/pmc05546412-204-3-14?v=ATCC
Average 99 stars, based on 1 article reviews
breast cancer cell lines - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC human breast cancer
Figure 7. EZH2 Inhibition Impairs Metastasis in TNBC Subtype-Specific PDX Models (A) EZH2 and GATA3 expression of the METABRIC dataset of 347 breast cancer patients, available in cBioportal and grouped by Pietenpol TNBC subtypes. Data represent median ± interquartile range (Wilcox t test). (B) Quantitative analysis of the invasive potential of <t>HCC1937</t> (BL-1), MDA-MB-468 (BL-1), BT-549 (M), CAL-120 (M), MDA-MB-453 (LAR), SUM185 (LAR), and CAL-148 (LAR) cell lines following treatment with vehicle or drug (5 mM GSK-126 for 5 days) and quantification of invasive cells of six distinct images in each replicate (n = 3) per group. The invasion of vehicle-treated cells was set at 1.
Human Breast Cancer, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+triple+negative+breast+cancer+cell+lines+hcc1937/pmc07257197-39-12-26?v=ATCC
Average 99 stars, based on 1 article reviews
human breast cancer - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC lymphoblastoid cell line hcc1937 bl
Figure 7. EZH2 Inhibition Impairs Metastasis in TNBC Subtype-Specific PDX Models (A) EZH2 and GATA3 expression of the METABRIC dataset of 347 breast cancer patients, available in cBioportal and grouped by Pietenpol TNBC subtypes. Data represent median ± interquartile range (Wilcox t test). (B) Quantitative analysis of the invasive potential of <t>HCC1937</t> (BL-1), MDA-MB-468 (BL-1), BT-549 (M), CAL-120 (M), MDA-MB-453 (LAR), SUM185 (LAR), and CAL-148 (LAR) cell lines following treatment with vehicle or drug (5 mM GSK-126 for 5 days) and quantification of invasive cells of six distinct images in each replicate (n = 3) per group. The invasion of vehicle-treated cells was set at 1.
Lymphoblastoid Cell Line Hcc1937 Bl, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+triple+negative+breast+cancer+cell+lines+hcc1937/pm38589490-270-2-16?v=ATCC
Average 99 stars, based on 1 article reviews
lymphoblastoid cell line hcc1937 bl - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC breast hcc 1937
Identification of RON mRNA transcripts with alterations in the first IPT Unit in colon, breast, and pancreatic cancer cells.
Breast Hcc 1937, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+triple+negative+breast+cancer+cell+lines+hcc1937/pmc03001714-74-15-27?v=ATCC
Average 99 stars, based on 1 article reviews
breast hcc 1937 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

Image Search Results


Figure 7. EZH2 Inhibition Impairs Metastasis in TNBC Subtype-Specific PDX Models (A) EZH2 and GATA3 expression of the METABRIC dataset of 347 breast cancer patients, available in cBioportal and grouped by Pietenpol TNBC subtypes. Data represent median ± interquartile range (Wilcox t test). (B) Quantitative analysis of the invasive potential of HCC1937 (BL-1), MDA-MB-468 (BL-1), BT-549 (M), CAL-120 (M), MDA-MB-453 (LAR), SUM185 (LAR), and CAL-148 (LAR) cell lines following treatment with vehicle or drug (5 mM GSK-126 for 5 days) and quantification of invasive cells of six distinct images in each replicate (n = 3) per group. The invasion of vehicle-treated cells was set at 1.

Journal: Cell reports

Article Title: Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer.

doi: 10.1016/j.celrep.2019.12.056

Figure Lengend Snippet: Figure 7. EZH2 Inhibition Impairs Metastasis in TNBC Subtype-Specific PDX Models (A) EZH2 and GATA3 expression of the METABRIC dataset of 347 breast cancer patients, available in cBioportal and grouped by Pietenpol TNBC subtypes. Data represent median ± interquartile range (Wilcox t test). (B) Quantitative analysis of the invasive potential of HCC1937 (BL-1), MDA-MB-468 (BL-1), BT-549 (M), CAL-120 (M), MDA-MB-453 (LAR), SUM185 (LAR), and CAL-148 (LAR) cell lines following treatment with vehicle or drug (5 mM GSK-126 for 5 days) and quantification of invasive cells of six distinct images in each replicate (n = 3) per group. The invasion of vehicle-treated cells was set at 1.

Article Snippet: Human breast cell lines MCF10A, MDA-MB-361, MCF7, MDA-MB-436, MDA-MB-231, BT-20, HCC1937, HCC1395, MDA-MB-468, DU4475, BT-549, SUM-159, CAL-120, CAL-148, MDA-MB-453 and SUM-185 were obtained from ATCC (Manassas, VA, USA) and DSMZ (Germany).

Techniques: Inhibition, Expressing

Identification of RON mRNA transcripts with alterations in the first IPT Unit in colon, breast, and pancreatic cancer cells.

Journal: Molecular Cancer

Article Title: Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase

doi: 10.1186/1476-4598-9-307

Figure Lengend Snippet: Identification of RON mRNA transcripts with alterations in the first IPT Unit in colon, breast, and pancreatic cancer cells.

Article Snippet: Human colon (HT-29, SW620, and SW837), breast (HCC-1937, MDA-MB231, T-47D, ZR-751, and MCF-7), and pancreatic (BxPc-3, L3.6pl, and Panc-1) cancer cell lines and NIH3T3 cells were from ATCC (Manassas, VA).

Techniques: